Mesoporous polydopamine-based nanodrug delivery systems for tumor immunotherapy.
Mesoporous polydopamine (MPDA) nanocarriers exhibit significant advantages in tumor drug delivery and immunotherapy owing to their well-defined mesoporous structure, modifiable surface chemistry, environmentally responsive degradation, and efficient photothermal properties. MPDA nanoparticles possess a high specific su...